METHOD FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA

摘要

the disclosure relates to a method of treatment or prevention of immune thrombocytopenic (itp) purpura (idiopathic) in a human being in need thereof, in which the method comprises administering to the human being in the range of 1 to 5 doses of an antibody anti-fcrn or antigen-binding fragment thereof during a treatment period of 1 to 12 weeks, in which the aggregated dose in the treatment period is in the range of 1 to 30 mg per kg.